FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011327377> ?p ?o ?g. }

• W2011327377 endingPage "104" @default.
• W2011327377 startingPage "97" @default.
• W2011327377 abstract "The silk-elastinlike protein polymer, SELP 815K, and poloxomer 407, a commercially available synthetic copolymer, were evaluated to compare their relative performance in matrix-mediated viral gene delivery. Using a xenogenic mouse tumor model of human head and neck squamous cell carcinoma, the efficacy of viral gene-directed enzyme prodrug therapy with these polymers was characterized by viral gene expression in the tumor tissue, tumor size reduction, and survivability with treatment. Viral injection in SELP 815K produced a greater level and more prolonged extent of gene expression in the tumor, a statistically greater tumor size reduction, a longer time until tumor rebound, and a significantly increased survivability, as compared to injection of virus alone or in Poloxamer 407. Safety of treatment with these polymers was evaluated in a non-tumor bearing immunocompetent mouse model. Compared to virus injected alone or in Poloxamer 407, virus injected in SELP 815K had fewer and less severe indications of toxicity related to treatment as assessed by blood analysis, body weight, and histopathology of distant organs and the injection sites. Similar to virus alone or in Poloxamer 407, virus injected in SELP 815K elicited a mild injection site inflammatory response characterized primarily by a mononuclear leukocyte infiltrate and the formation of granulation tissue. Virus injected in SELP 815K resulted in fewer animals with elevated white blood cell counts and a less pronounced local toxicity reaction than was observed with virus in Poloxamer 407. In contrast to virus injected alone or in Poloxamer 407, which were not retained in the injection site tissues beyond week 1, SELP 815K was retained at the injection sites and by the end of the study (week 12), displayed limited absorption, and mild encapsulation. These results demonstrate the benefits of SELP 815K for matrix-mediated gene delivery over the injection of free virus and the injection of virus in Poloxamer 407. Virus in SELP 815K had greater efficacy of tumor suppression, promoted greater levels and greater duration of viral gene expression, and displayed reduced levels of injection site toxicity. Combining these performance and safety benefits with the degree of control with which they can be designed, synthesized and formulated, SELPs continue to show promise for their application in viral gene delivery." @default.
• W2011327377 created "2016-06-24" @default.
• W2011327377 creator A5015455232 @default.
• W2011327377 creator A5022997488 @default.
• W2011327377 creator A5045826985 @default.
• W2011327377 creator A5079532419 @default.
• W2011327377 creator A5082563491 @default.
• W2011327377 creator A5091405085 @default.
• W2011327377 date "2012-05-01" @default.
• W2011327377 modified "2023-10-17" @default.
• W2011327377 title "Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery" @default.
• W2011327377 cites W1481565655 @default.
• W2011327377 cites W1965552500 @default.
• W2011327377 cites W1969604041 @default.
• W2011327377 cites W1971558668 @default.
• W2011327377 cites W1973356828 @default.
• W2011327377 cites W1982805293 @default.
• W2011327377 cites W1983208410 @default.
• W2011327377 cites W1997356166 @default.
• W2011327377 cites W1998165633 @default.
• W2011327377 cites W2009679024 @default.
• W2011327377 cites W2027672562 @default.
• W2011327377 cites W2040837189 @default.
• W2011327377 cites W2044310607 @default.
• W2011327377 cites W2048953807 @default.
• W2011327377 cites W2049357072 @default.
• W2011327377 cites W2066606615 @default.
• W2011327377 cites W2075692927 @default.
• W2011327377 cites W2091359362 @default.
• W2011327377 cites W2115552610 @default.
• W2011327377 cites W2145439412 @default.
• W2011327377 cites W2170468591 @default.
• W2011327377 cites W2170533808 @default.
• W2011327377 cites W2170654416 @default.
• W2011327377 doi "https://doi.org/10.1016/j.ijpharm.2011.09.037" @default.
• W2011327377 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3305828" @default.
• W2011327377 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21982738" @default.
• W2011327377 hasPublicationYear "2012" @default.
• W2011327377 type Work @default.
• W2011327377 sameAs 2011327377 @default.
• W2011327377 citedByCount "34" @default.
• W2011327377 countsByYear W20113273772012 @default.
• W2011327377 countsByYear W20113273772013 @default.
• W2011327377 countsByYear W20113273772014 @default.
• W2011327377 countsByYear W20113273772015 @default.
• W2011327377 countsByYear W20113273772016 @default.
• W2011327377 countsByYear W20113273772017 @default.
• W2011327377 countsByYear W20113273772019 @default.
• W2011327377 countsByYear W20113273772020 @default.
• W2011327377 countsByYear W20113273772021 @default.
• W2011327377 countsByYear W20113273772022 @default.
• W2011327377 countsByYear W20113273772023 @default.
• W2011327377 crossrefType "journal-article" @default.
• W2011327377 hasAuthorship W2011327377A5015455232 @default.
• W2011327377 hasAuthorship W2011327377A5022997488 @default.
• W2011327377 hasAuthorship W2011327377A5045826985 @default.
• W2011327377 hasAuthorship W2011327377A5079532419 @default.
• W2011327377 hasAuthorship W2011327377A5082563491 @default.
• W2011327377 hasAuthorship W2011327377A5091405085 @default.
• W2011327377 hasBestOaLocation W20113273772 @default.
• W2011327377 hasConcept C101335993 @default.
• W2011327377 hasConcept C104317684 @default.
• W2011327377 hasConcept C111599444 @default.
• W2011327377 hasConcept C135983454 @default.
• W2011327377 hasConcept C142724271 @default.
• W2011327377 hasConcept C153911025 @default.
• W2011327377 hasConcept C15920480 @default.
• W2011327377 hasConcept C178790620 @default.
• W2011327377 hasConcept C185592680 @default.
• W2011327377 hasConcept C203014093 @default.
• W2011327377 hasConcept C2522874641 @default.
• W2011327377 hasConcept C2780306666 @default.
• W2011327377 hasConcept C2781264782 @default.
• W2011327377 hasConcept C521977710 @default.
• W2011327377 hasConcept C55493867 @default.
• W2011327377 hasConcept C71924100 @default.
• W2011327377 hasConcept C86803240 @default.
• W2011327377 hasConcept C8891405 @default.
• W2011327377 hasConcept C98274493 @default.
• W2011327377 hasConceptScore W2011327377C101335993 @default.
• W2011327377 hasConceptScore W2011327377C104317684 @default.
• W2011327377 hasConceptScore W2011327377C111599444 @default.
• W2011327377 hasConceptScore W2011327377C135983454 @default.
• W2011327377 hasConceptScore W2011327377C142724271 @default.
• W2011327377 hasConceptScore W2011327377C153911025 @default.
• W2011327377 hasConceptScore W2011327377C15920480 @default.
• W2011327377 hasConceptScore W2011327377C178790620 @default.
• W2011327377 hasConceptScore W2011327377C185592680 @default.
• W2011327377 hasConceptScore W2011327377C203014093 @default.
• W2011327377 hasConceptScore W2011327377C2522874641 @default.
• W2011327377 hasConceptScore W2011327377C2780306666 @default.
• W2011327377 hasConceptScore W2011327377C2781264782 @default.
• W2011327377 hasConceptScore W2011327377C521977710 @default.
• W2011327377 hasConceptScore W2011327377C55493867 @default.
• W2011327377 hasConceptScore W2011327377C71924100 @default.
• W2011327377 hasConceptScore W2011327377C86803240 @default.
• W2011327377 hasConceptScore W2011327377C8891405 @default.
• W2011327377 hasConceptScore W2011327377C98274493 @default.

• next